Cargando…
Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) 1,4-benzoquinone (CV-6504).
2,3,5-Trimethyl-6-(3-pyridylmethyl) 1,4-benzoquinone (CV-6504), an inhibitor of 5-lipoxygenase, effectively suppressed growth of the MAC16 tumour in vivo and prevented the accompanying cachexia, when administered daily at a dose of 10 mg kg(-1). There was a reduction in the tumour concentration of l...
Autores principales: | Hussey, H. J., Tisdale, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063397/ https://www.ncbi.nlm.nih.gov/pubmed/9062405 |
Ejemplares similares
-
Metabolism and pharmacokinetics of the anti-tumour agent 2,3,5-trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504).
por: Hussey, H. J., et al.
Publicado: (1996) -
Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).
por: Hussey, H. J., et al.
Publicado: (1996) -
2,3,5-Trimethyl-1,4-hydroquinone
por: Dai, Jun, et al.
Publicado: (2010) -
4-Amino-2,3,5-trimethylpyridine monohydrate
por: Dai, Li-Yan, et al.
Publicado: (2009) -
Untargeted metabolomics of human keratinocytes reveals the impact of exposure to 2,6-dichloro-1,4-benzoquinone and 2,6-dichloro-3-hydroxy-1,4-benzoquinone as emerging disinfection by-products
por: Meintani, Dimitra G., et al.
Publicado: (2022)